Webinare

Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments

14 Mar 2024

on demand

Tags: Invivoscribe, Next-Generation Sequencing, NGS, webinar, MRD, LymphoTrack® , AML

Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring

2 Feb 2023

Tuesday, 28.02.2023
19.00 - 20.00 o'clock

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Klonalität , Clonality , B-Zellen, B-cells, MRD, LymphoTrack® , CLL, Chronic Lymphocytic Leukemia, multiparameter flow cytometric (MFC), webinar

NGS-based MRD Testing for Acute Lymphoblastic Leukemia

8 Nov 2022

Tuesday, 11/15/2022
7.00 - 8.00 pm CET

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells, MRD, LymphoTrack®

Next-Generation Sequencing of Immunoglobulin Genes in Lymphoid Malignancies

5 May 2022

Identify genes targeted for clonality assessment in B-cell malignancies
Compare sequencing techniques used for immunoglobulin genes
Describe pre-analytical variables that impact immunoglobulin sequencing
Contrast clonality analysis by next-generation sequencing to traditional non-sequencing methods

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells

Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing

17 Feb 2022

• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)

Tags: Invivoscribe, Leukemia , Multiple Myeloma, Morbus Kahler , Leukämie, ALL , Akute Lymphatische Leukämie, MRD, Messbare (minimale) Resterkrankung (MRD), Minimal Residual Disease (MRD)

Molecular FLT3 diagnostics in AML

26 Mar 2021

Practical example from the

Tags: FLT3, Leukostrat, Invivoscribe, AML, IVDR